AstraZeneca PLC (AZN)
90.67
-0.84
(-0.92%)
USD |
NASDAQ |
Dec 11, 15:28
AstraZeneca Shareholders Equity (Quarterly): 45.89B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| GSK Plc | 21.74B |
| Amgen, Inc. | 9.619B |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Autolus Therapeutics Plc | 265.45M |
| Moderna, Inc. | 9.33B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 114.46B |
| Total Liabilities (Quarterly) | 68.48B |
| Debt to Equity Ratio | 0.7111 |
| Current Ratio | 0.8792 |
| Net Debt Paydown Yield | 0.08% |